Tetrazole and ester substituted tetrahydoquinoxalines as potent cholesteryl ester transfer protein inhibitors
- 1 May 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (9) , 2608-2613
- https://doi.org/10.1016/j.bmcl.2007.01.112
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Oral Cholesteryl Ester Transfer Protein (CETP) Inhibitors: A Potential New Approach for Treating Coronary Artery DiseaseJournal of Medicinal Chemistry, 2005
- Strategies to promote HDL-C: an emerging therapeutic targetEuropean Heart Journal, 2005
- Increasing HDL Cholesterol LevelsNew England Journal of Medicine, 2004
- Raising High-Density Lipoprotein in Humans Through Inhibition of Cholesteryl Ester Transfer ProteinArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trialsInt. Journal of Clinical Pharmacology and Therapeutics, 2003
- 5-Substituted-1H-tetrazoles as carboxylic acid isosteres: medicinal chemistry and synthetic methodsBioorganic & Medicinal Chemistry, 2002
- Bis(2-(Acylamino)phenyl) Disulfides, 2-(Acylamino)benzenethiols, and S-(2-(Acylamino)phenyl) Alkanethioates as Novel Inhibitors of Cholesteryl Ester Transfer ProteinJournal of Medicinal Chemistry, 2000
- Increased High-Density Lipoprotein Levels Caused by a Common Cholesteryl-Ester Transfer Protein Gene MutationNew England Journal of Medicine, 1990
- Alkylation and condensation reactions of N,N-dibenzylglycine esters: synthesis of α-amino acid derivativesJournal of the Chemical Society, Chemical Communications, 1987
- Rapid chromatographic technique for preparative separations with moderate resolutionThe Journal of Organic Chemistry, 1978